GeneLink, Inc. (OTCBB: GNLK, "the Company," or "GeneLink"), a leading consumer genomics biotech company, today reported financial results for the fiscal year ended December 31, 2010.
Financial Highlights:
-- Gross margin increased from $4,906,710 in 2009 to $4,997,367 in 2010;
-- Annual net sales decreased 8.4%, $7,839,972 for 2010 as compared to
$8,561,455 in 2009;
-- Operating losses in 2010 decreased to ...
read more